Different inflammatory mechanisms in lungs of severe and mild asthma: crosstalk of NF‐kappa‐B, TGFβ1, Bax, Bcl‐2, IL‐4 and IgE

References

• Bosse Y, Rola‐Pleszczynski M. Controversy surrounding the increased expression of TGF beta 1 in asthma. Respir Res 2007; 8: 66
   PubMed Web of Science ®Google Scholar
• United States National Heart, Lung and Blood Institute Available at:. http://www.nhlbi.nih.gov/
   Google Scholar
• Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997; 88: 347–54
   PubMed Web of Science ®Google Scholar
• Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 2008; 9: 231–41
   PubMed Web of Science ®Google Scholar
• Sturm Ade Souza HS, Fiocchi C. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease. Curr Drug Targets 2008; 9: 381–7
   PubMed Web of Science ®Google Scholar
• Nevzorova VA, Suvorenko TN, Konovalova EN. Apoptosis and inflammation in bronchial asthma. Ter Arkh 2001; 73: 92–6
   PubMed Web of Science ®Google Scholar
• Duvernelle C, Freund V, Frossard N. Transforming growth factor‐beta and its role in asthma. Pulm Pharmacol Ther 2003; 16: 181–96
   PubMed Web of Science ®Google Scholar
• Howell JE, McAnulty RJ. TGF‐beta: its role in asthma and therapeutic potential. Curr Drug Targets 2006; 7: 547–65
   PubMed Web of Science ®Google Scholar
• Makinde T, Murphy RF, Agrawal DK. The regulatory role of TGFbeta in airway remodeling in asthma. Immunol Cell Biol 2007
   Google Scholar
• Karagiannidis C, Hense G, Martin C, Epstein M, Ruckert B, Mantel PY, et al. Activin A is an acute allergen‐responsive cytokine and provides a link to TGF‐beta‐mediated airway remodeling in asthma. J Allergy Clin Immunol 2006; 117: 111–18
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Hirano T, Nakanishi M, Yamagata T, Minakata Y, Ichinose M. Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J Allergy Clin Immunol 2006; 118: 84–90
   PubMed Web of Science ®Google Scholar
• Balzar S, Chu HW, Silkoff P, Cundall M, Trudeau JB, Strand M, Wenzel S. Increased TGF‐beta2 in severe asthma with eosinophilia. J Allergy Clin Immunol 2005; 115: 110–17
   PubMed Web of Science ®Google Scholar
• Torrego A, Hew M, Oates T, Sukkar M, Fan Chung K. Expression and activation of TGF‐beta isoforms in acute allergen induced remodelling in asthma. Thorax 2007; 62: 307–13
   PubMed Web of Science ®Google Scholar
• Schmidt‐Weber CB, Blaser K. The role of TGF‐beta in allergic inflammation. Immunol Allergy Clin North Am 2006; 26: 233–44
   PubMed Web of Science ®Google Scholar
• Pereira SG, Oakley F. Nuclear factor‐kappaB1: regulation and function. Int J Biochem Cell Biol 2008; 40: 1425–30
   PubMed Web of Science ®Google Scholar
• Christman JW, Sadikot RT, Blackwell TS. The role of nuclear factor‐kappa B in pulmonary diseases. Chest 2000; 117: 1482–7
   PubMed Web of Science ®Google Scholar
• Wright JG, Christman JW. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med 2003; 2: 211–19
   PubMedGoogle Scholar
• Kuperman DA, Schleimer RP. Interleukin‐4, interleukin‐13, signal transducer and activator of transcription factor 6, and allergic asthma. Curr Mol Med 2008; 8: 384–92
   PubMed Web of Science ®Google Scholar
• Isidoro‐Garcia M, Davila I, Laffond E, Moreno E, Lorente F, Gonzalez‐Sarmiento R. Interleukin‐4 (IL4) and Interleukin‐4 receptor (IL4RA) polymorphisms in asthma: a case control study. Clin Mol Allergy 2005; 3: 15–20
   PubMedGoogle Scholar
• Yamaguchi E, Okazaki N, Tuneta Y, Abe S, Terai T, Kawakami Y. Interleukins in pulmonary sarcoidosis: dissociative correlations of lung interleukins 1 and 2 with the intensity of alveolitis. Am Rev Respir Dis 1988; 138: 645–51
   PubMedGoogle Scholar
• Tsao TC, Chen CH, Hong JH, Hsieh MJ, Tsao KC, Lee CH. Shifts of T4/T8 T lymphocytes from BAL fluid and peripheral blood by clinical grade in patients with pulmonary tuberculosis. Chest 2002; 122: 1285–91
   PubMed Web of Science ®Google Scholar
• Schuurs A, Weeman V. Enzyme immunoassay. Clin Chem Acta 1977; 31: 1–40
   Web of Science ®Google Scholar
• Borish L, Culp JA. Asthma: a syndrome composed of heterogeneous diseases. Ann Allergy Asthma Immunol 2008; 101: 8–11
   Web of Science ®Google Scholar
• Walters EH, Bjermer L, Faurschou P, Sandstrom T. The anti‐inflammatory profile of inhaled corticosteroids combined with salmeterol in asthmatic patients. Respir Med 2000; 94(Suppl F)S26–31
   PubMed Web of Science ®Google Scholar
• Hansen G, Berry G, DeKrayf RH, Umetsu DT. Allergen specific Th1 cells fail to counterbalance Th2 cells induced airway hypereactivity but cause sever airway inflammation. J Clin Invest 1999; 103: 175–83
   PubMed Web of Science ®Google Scholar
• Pilette C, Ouadriri Y, Godding V, Vaerman JP, Sibille Y. Lung mucosal immunity: immunoglobulin‐A revisited. Eur Respir J 2001; 18: 571–88
   PubMed Web of Science ®Google Scholar
• Kunkel EJ, Butcher EC. Plasma‐cell homing. Nat Rev Immunol 2003; 3: 822–29
   PubMed Web of Science ®Google Scholar
• Herrmann JL, Beham AW, Sarkiss M, Chiao PJ, Rands MT, Bruckheimer EM, Brisbay S, McDonnell TJ. Bcl‐2 suppresses apoptosis resulting from disruption of the NF‐kappa B survival pathway. Exp Cell Res 1997; 237: 101–9
   PubMed Web of Science ®Google Scholar
• Chen GG, Liang NC, Lee JF, Chan UP, Wang SH, Leung BC, Leung KL. Over‐expression of Bcl‐2 against Pteris semipinnata L‐induced apoptosis of human colon cancer cells via a NF‐kappa B‐related pathway. Apoptosis 2004; 9: 619–27
   PubMed Web of Science ®Google Scholar
• Viatour P, Bentires‐Alj M, Chariot A, Deregowski V, de Leval L, Merville MP, Bours V. NF‐kappa B2/p100 induces Bcl‐2 expression. Leukemia 2003; 17: 1349–56
   PubMed Web of Science ®Google Scholar
• El‐Gamal Y, Heshmat N, Mahran M, El‐Gabbas Z. Expression of the apoptosis inhibitor Bcl‐2 in sputum eosinophils from children with acute asthma. Clin Exp Allergy 2004; 34: 1701–6
   PubMed Web of Science ®Google Scholar
• Jang AS, Choi IS, Lee S, Seo JP, Yang SW, Park CS. Bcl‐2 expression in sputum eosinophils in patients with acute asthma. Thorax 2000; 55: 370–4
   PubMed Web of Science ®Google Scholar
• Warshamana GS, Corti M, Brody AR. TNF‐alpha, PDGF, and TGF‐beta(1) expression by primary mouse bronchiolar‐alveolar epithelial and mesenchymal cells: tnf‐alpha induces TGF‐beta(1). Exp Mol Pathol 2001; 71: 13–33
   PubMed Web of Science ®Google Scholar
• Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA. Interleukin‐13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001; 194: 809–21
   PubMed Web of Science ®Google Scholar
• Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J. Transforming growth factor‐beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156: 591–9
   PubMed Web of Science ®Google Scholar
• Coker RK, Laurent GJ, Shahzeidi S, Hernandez‐Rodriguez NA, Pantelidis P, du Bois RM, Jeffery PK, McAnulty RJ. Diverse cellular TGFbeta 1 and TGF‐beta 3 gene expression in normal human and murine lung. Eur Respir J 1996; 9: 2501–7
   PubMed Web of Science ®Google Scholar
• de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1951–7
   PubMed Web of Science ®Google Scholar
• Scherf W, Burdach S, Hansen G. Reduced expression of transforming growth factor beta 1 exacerbates pathology in an experimental asthma model. Eur J Immunol 2005; 35: 198–206
   PubMed Web of Science ®Google Scholar
• Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke GJ, Chen L, DeKruyff RH, Umetsu DT. CD4(+) T helper cells engineered to produce latent TGF‐beta1 reverse allergen‐induced airway hyperreactivity and inflammation. J Clin Invest 2000; 105: 61–70
   PubMed Web of Science ®Google Scholar
• Berger P, Girodet PO, Manuel Tunon‐de‐Lara J. Mast cell myositis: a new feature of allergic asthma?. Allergy 2005; 60: 1238–40
   PubMed Web of Science ®Google Scholar
• Gruber BL, Marchese MJ, Kew RR. Transforming growth factorbeta 1 mediates mast cell chemotaxis. J Immunol 1994; 152: 5860–7
   PubMed Web of Science ®Google Scholar
• Virchow JC, Kroegel C, Walker C, Matthys H. Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J Allergy Clin Immunol 1996; 98: 27–33
   PubMed Web of Science ®Google Scholar
• Tillie‐Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999; 159: 487–94
   PubMed Web of Science ®Google Scholar
• Nichols TC, Fischer TH, Deliargyris EN, Baldwin AS. Role of nuclear factor‐kappa B (NF‐kappa B) in inflammation periodontitis, and atherogenesis. Ann Periodontol 2001; 6: 20–9
   PubMedGoogle Scholar